Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2012

View Archived Issues

Team at Merrimack Pharmaceuticals designs new bispecific antibodies

AstraZeneca profiles novel dual chemokine CCR3/histamine H1 receptor antagonists

Gilead's GS-967 suppresses experimental arrhythmias

New TRPV4 channel ligands divulged by Shionogi

Promising results presented for a novel malaria vaccine

Novel antipsychotics created at Roche

King Saud University and Terramark design new anti-inflammatory agents

Arena Pharmaceuticals divulges novel GRP119 receptor agonists

Ligand Pharmaceuticals presents a novel HepDirect prodrug with excellent oral bioavailability

Enhanced genetically encoded calcium indicators described / News in Context: Optogenetics

ImmunoGen patents novel cancer therapeutics

New antivirals designed by University of Pennsylvania

University of Missouri discloses novel TNF-alpha production inhibitors

EMA recommends granting orphan status to Aspireo's somatoprim

GS-432780-5 and GS-443023-6 show promise in mouse models of chronic liver injury

Alfama designs novel therapy against liver pathology

Discovery of AZ-12436092 reported by AstraZeneca researchers

Pharming receives milestone payment from Santarus

CLSPN gene mutations identified in glioma patients

Phase IIb JX-594 trial begins in Hong Kong

Murdoch Childrens opens Australian site in global study of BioMarin's achondroplasia treatment

AstraZeneca and Pfizer partnership establishes life sciences research center

Recruitment complete in phase I study of ATX-MS-1467

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...